#$%^&*AU2013234421B220150827.pdf#####CHLORITE FORMULATIONS, AND METHODS OF PREPARATION AND USE THEREOF ABSTRACT OF THE DISCLOSURE [001591 Described herein are chlorite formulations having a pH between about 7 and about 8.5, wherein the chlorite formulations are substantially free of deleterious non-chlorite components. Described herein are chlorite 5 formulations, including pharmaceutical formulations, which are formulated for systemic, parenteral, or intravenous administration. Described herein are methods of preparing and methods of using the chlorite formulations described herein.